APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hemostatic Agents

Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.

Selected research

Industry Growth & Trends

Global Hemostatic Agents Industry Growth and Trends Forecast to 2032

Report ID 173997650125 December 2025119 pages

Choose your research edition.

Industry ResearchHemostatic Agents Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemostatic Agents Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Hemostatic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemostatic Agents Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemostatic Agents Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.

The world's leading manufacturers of hemostatics are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LiLifeSciences, B Braun Melsungen and Gelita Medical.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Hemostatic Agents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hemostatic Agents market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hemostatic Agents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hemostatic Agents.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hemostatic Agents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hemostatic Agents Market by Company

Ethicon

Pfizer

Baxter International

C. R. Bard

The Medicines Company

Anika Therapeutics

Advanced Medical Solutions

Integra LifeSciences

B Braun Melsungen

Gelita Medical

Equimedical

Vascular Solutions

Marine Polymer Technologies

Z-Medica

CryoLife

BioCer Entwicklungs

Biom’Up SAS

Hemostatic Agents Segment by Type

Gelation Sponge

Oxidized Regenerated Cellulose Based Hemostats

Others

Hemostatic Agents Segment by Application

Hospitals

Surgical Centers

Nursing Homes

Hemostatic Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemostatic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatic Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemostatic Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Gelation Sponge Table 2. Major Company of Oxidized Regenerated Cellulose Based Hemostats Table 3. Major Company of Others Table 4. Global Hemostatic Agents Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 6. Global Hemostatic Agents Sales Market Share in Volume by Type (2021-2026) Table 7. Global Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 8. Global Hemostatic Agents Sales Market Share in Value by Type (2021-2026) Table 9. Global Hemostatic Agents Price by Type (2021-2026) & (USD/Unit) Table 10. Global Hemostatic Agents Sales by Type (2027-2032) & (K Units) Table 11. Global Hemostatic Agents Sales Market Share in Volume by Type (2027-2032) Table 12. Global Hemostatic Agents Sales by Type (2027-2032) & (US$ Million) Table 13. Global Hemostatic Agents Sales Market Share in Value by Type (2027-2032) Table 14. Global Hemostatic Agents Price by Type (2027-2032) & (USD/Unit) Table 15. North America Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 16. North America Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 18. Europe Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 22. Latin America Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 25. Hemostatic Agents Industry Trends Table 26. Hemostatic Agents Industry Drivers Table 27. Hemostatic Agents Industry Opportunities and Challenges Table 28. Hemostatic Agents Industry Restraints Table 29. Global Hemostatic Agents Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Hemostatic Agents Revenue Market Share by Company (2021-2026) Table 31. Global Hemostatic Agents Sales by Company (2021-2026) & (K Units) Table 32. Global Hemostatic Agents Sales Share by Company (2021-2026) Table 33. Global Hemostatic Agents Market Price by Company (2021-2026) & (USD/Unit) Table 34. Global Hemostatic Agents Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Hemostatic Agents Major Company Production Sites and Headquarters Table 36. Global Hemostatic Agents Company, Product Type & Application Table 37. Global Hemostatic Agents Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Hemostatic Agents Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Hemostatic Agents Sales by Region (2021-2026) & (K Units) Table 42. Global Hemostatic Agents Sales Market Share in Volume by Region (2021-2026) Table 43. Global Hemostatic Agents Sales by Region (2021-2026) & (US$ Million) Table 44. Global Hemostatic Agents Sales Market Share in Value by Region (2021-2026) Table 45. Global Hemostatic Agents Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 46. Global Hemostatic Agents Sales by Region (2027-2032) & (K Units) Table 47. Global Hemostatic Agents Sales Market Share in Volume by Region (2027-2032) Table 48. Global Hemostatic Agents Sales by Region (2027-2032) & (US$ Million) Table 49. Global Hemostatic Agents Sales Market Share in Value by Region (2027-2032) Table 50. Global Hemostatic Agents Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 51. Global Hemostatic Agents Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 53. Global Hemostatic Agents Sales Market Share in Volume by Application (2021-2026) Table 54. Global Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 55. Global Hemostatic Agents Sales Market Share in Value by Application (2021-2026) Table 56. Global Hemostatic Agents Price by Application (2021-2026) & (USD/Unit) Table 57. Global Hemostatic Agents Sales by Application (2027-2032) & (K Units) Table 58. Global Hemostatic Agents Sales Market Share in Volume by Application (2027-2032) Table 59. Global Hemostatic Agents Sales by Application (2027-2032) & (US$ Million) Table 60. Global Hemostatic Agents Sales Market Share in Value by Application (2027-2032) Table 61. Global Hemostatic Agents Price by Application (2027-2032) & (USD/Unit) Table 62. North America Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 63. North America Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 65. Europe Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 69. Latin America Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 72. Ethicon Company Information Table 73. Ethicon Business Overview Table 74. Ethicon Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 75. Ethicon Hemostatic Agents Product Portfolio Table 76. Ethicon Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 80. Pfizer Hemostatic Agents Product Portfolio Table 81. Pfizer Recent Development Table 82. Baxter International Company Information Table 83. Baxter International Business Overview Table 84. Baxter International Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 85. Baxter International Hemostatic Agents Product Portfolio Table 86. Baxter International Recent Development Table 87. C. R. Bard Company Information Table 88. C. R. Bard Business Overview Table 89. C. R. Bard Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. C. R. Bard Hemostatic Agents Product Portfolio Table 91. C. R. Bard Recent Development Table 92. The Medicines Company Company Information Table 93. The Medicines Company Business Overview Table 94. The Medicines Company Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. The Medicines Company Hemostatic Agents Product Portfolio Table 96. The Medicines Company Recent Development Table 97. Anika Therapeutics Company Information Table 98. Anika Therapeutics Business Overview Table 99. Anika Therapeutics Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. Anika Therapeutics Hemostatic Agents Product Portfolio Table 101. Anika Therapeutics Recent Development Table 102. Advanced Medical Solutions Company Information Table 103. Advanced Medical Solutions Business Overview Table 104. Advanced Medical Solutions Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. Advanced Medical Solutions Hemostatic Agents Product Portfolio Table 106. Advanced Medical Solutions Recent Development Table 107. Integra LifeSciences Company Information Table 108. Integra LifeSciences Business Overview Table 109. Integra LifeSciences Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. Integra LifeSciences Hemostatic Agents Product Portfolio Table 111. Integra LifeSciences Recent Development Table 112. B Braun Melsungen Company Information Table 113. B Braun Melsungen Business Overview Table 114. B Braun Melsungen Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 115. B Braun Melsungen Hemostatic Agents Product Portfolio Table 116. B Braun Melsungen Recent Development Table 117. Gelita Medical Company Information Table 118. Gelita Medical Business Overview Table 119. Gelita Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 120. Gelita Medical Hemostatic Agents Product Portfolio Table 121. Gelita Medical Recent Development Table 122. Equimedical Company Information Table 123. Equimedical Business Overview Table 124. Equimedical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 125. Equimedical Hemostatic Agents Product Portfolio Table 126. Equimedical Recent Development Table 127. Vascular Solutions Company Information Table 128. Vascular Solutions Business Overview Table 129. Vascular Solutions Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 130. Vascular Solutions Hemostatic Agents Product Portfolio Table 131. Vascular Solutions Recent Development Table 132. Marine Polymer Technologies Company Information Table 133. Marine Polymer Technologies Business Overview Table 134. Marine Polymer Technologies Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 135. Marine Polymer Technologies Hemostatic Agents Product Portfolio Table 136. Marine Polymer Technologies Recent Development Table 137. Z-Medica Company Information Table 138. Z-Medica Business Overview Table 139. Z-Medica Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 140. Z-Medica Hemostatic Agents Product Portfolio Table 141. Z-Medica Recent Development Table 142. CryoLife Company Information Table 143. CryoLife Business Overview Table 144. CryoLife Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 145. CryoLife Hemostatic Agents Product Portfolio Table 146. CryoLife Recent Development Table 147. BioCer Entwicklungs Company Information Table 148. BioCer Entwicklungs Business Overview Table 149. BioCer Entwicklungs Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 150. BioCer Entwicklungs Hemostatic Agents Product Portfolio Table 151. BioCer Entwicklungs Recent Development Table 152. Biom’Up SAS Company Information Table 153. Biom’Up SAS Business Overview Table 154. Biom’Up SAS Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 155. Biom’Up SAS Hemostatic Agents Product Portfolio Table 156. Biom’Up SAS Recent Development Table 157. North America Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. North America Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 159. North America Hemostatic Agents Sales Market Share by Country (2021-2026) Table 160. North America Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 161. North America Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 162. North America Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. North America Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 164. North America Hemostatic Agents Market Share by Country (2021-2026) Table 165. North America Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. North America Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 167. Europe Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Europe Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 169. Europe Hemostatic Agents Sales Market Share by Country (2021-2026) Table 170. Europe Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 171. Europe Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 172. Europe Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Europe Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 174. Europe Hemostatic Agents Market Share by Country (2021-2026) Table 175. Europe Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Europe Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 177. Asia-Pacific Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Asia-Pacific Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 179. Asia-Pacific Hemostatic Agents Sales Market Share by Country (2021-2026) Table 180. Asia-Pacific Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 181. Asia-Pacific Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 182. Asia-Pacific Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Asia-Pacific Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 184. Asia-Pacific Hemostatic Agents Market Share by Country (2021-2026) Table 185. Asia-Pacific Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Asia-Pacific Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 187. Latin America Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 188. Latin America Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 189. Latin America Hemostatic Agents Sales Market Share by Country (2021-2026) Table 190. Latin America Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 191. Latin America Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 192. Latin America Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Latin America Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 194. Latin America Hemostatic Agents Market Share by Country (2021-2026) Table 195. Latin America Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Latin America Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 197. Middle East and Africa Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 198. Middle East and Africa Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 199. Middle East and Africa Hemostatic Agents Sales Market Share by Country (2021-2026) Table 200. Middle East and Africa Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 201. Middle East and Africa Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 202. Middle East and Africa Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 203. Middle East and Africa Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 204. Middle East and Africa Hemostatic Agents Market Share by Country (2021-2026) Table 205. Middle East and Africa Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 206. Middle East and Africa Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 207. Key Raw Materials Table 208. Raw Materials Key Suppliers Table 209. Hemostatic Agents Distributors List Table 210. Hemostatic Agents Customers List Table 211. Research Programs/Design for This Report Table 212. Authors List of This Report Table 213. Secondary Sources Table 214. Primary Sources List of Figures Figure 1. Hemostatic Agents Image Figure 2. Global Hemostatic Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemostatic Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemostatic Agents Sales (2021-2032) & (K Units) Figure 5. Gelation Sponge Image Figure 6. Global Gelation Sponge Sales YoY Growth (2021-2032) & (K Units) Figure 7. Oxidized Regenerated Cellulose Based Hemostats Image Figure 8. Global Oxidized Regenerated Cellulose Based Hemostats Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Hemostatic Agents Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Hemostatic Agents Market Share by Type 2025 VS 2032 Figure 13. North America Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 14. North America Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 15. Europe Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 16. Europe Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 19. Latin America Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Hemostatic Agents Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Surgical Centers Image Figure 28. Global Surgical Centers Sales YoY Growth (2021-2032) & (K Units) Figure 29. Nursing Homes Image Figure 30. Global Nursing Homes Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Hemostatic Agents Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Hemostatic Agents Market Share by Application 2025 VS 2032 Figure 33. North America Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 34. North America Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 35. Europe Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 36. Europe Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 39. Latin America Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 43. North America Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Hemostatic Agents Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Hemostatic Agents Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Gelation Sponge
  • Oxidized Regenerated Cellulose Based Hemostats
  • Others
Applications
  • Hospitals
  • Surgical Centers
  • Nursing Homes
Companies covered
  • Ethicon
  • Pfizer
  • Baxter International
  • C. R. Bard
  • The Medicines Company
  • Anika Therapeutics
  • Advanced Medical Solutions
  • Integra LifeSciences
  • B Braun Melsungen
  • Gelita Medical
  • Equimedical
  • Vascular Solutions
  • Marine Polymer Technologies
  • Z-Medica
  • CryoLife
  • BioCer Entwicklungs
  • Biom’Up SAS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hemostatic Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hemostatic Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hemostatic Agents Market by Type
  6. 1.3.1 Gelation Sponge
  7. 1.3.2 Oxidized Regenerated Cellulose Based Hemostats
  8. 1.3.3 Others
  9. 1.4 Global Hemostatic Agents Market Size by Type
  10. 1.4.1 Global Hemostatic Agents Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Hemostatic Agents Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Hemostatic Agents Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Hemostatic Agents Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Hemostatic Agents Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Hemostatic Agents Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Hemostatic Agents Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Hemostatic Agents Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hemostatic Agents Industry Trends
  2. 2.2 Hemostatic Agents Industry Drivers
  3. 2.3 Hemostatic Agents Industry Opportunities and Challenges
  4. 2.4 Hemostatic Agents Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hemostatic Agents Revenue (2021-2026)
  2. 3.2 Global Top Players by Hemostatic Agents Sales (2021-2026)
  3. 3.3 Global Top Players by Hemostatic Agents Price (2021-2026)
  4. 3.4 Global Hemostatic Agents Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemostatic Agents Major Company Production Sites & Headquarters
  6. 3.6 Global Hemostatic Agents Company, Product Type & Application
  7. 3.7 Global Hemostatic Agents Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemostatic Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemostatic Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemostatic Agents Tier 1, Tier 2, and Tier 3
4 Hemostatic Agents Regional Status and Outlook
  1. 4.1 Global Hemostatic Agents Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hemostatic Agents Historic Market Size by Region
  3. 4.2.1 Global Hemostatic Agents Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hemostatic Agents Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hemostatic Agents Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hemostatic Agents Forecasted Market Size by Region
  7. 4.3.1 Global Hemostatic Agents Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hemostatic Agents Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hemostatic Agents Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hemostatic Agents by Application
  1. 5.1 Hemostatic Agents Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Surgical Centers
  4. 5.1.3 Nursing Homes
  5. 5.2 Global Hemostatic Agents Market Size by Application
  6. 5.2.1 Global Hemostatic Agents Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Hemostatic Agents Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Hemostatic Agents Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Hemostatic Agents Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Hemostatic Agents Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Hemostatic Agents Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Hemostatic Agents Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Hemostatic Agents Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ethicon
  2. 6.1.1 Ethicon Company Information
  3. 6.1.2 Ethicon Business Overview
  4. 6.1.3 Ethicon Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ethicon Hemostatic Agents Product Portfolio
  6. 6.1.5 Ethicon Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Hemostatic Agents Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Baxter International
  14. 6.3.1 Baxter International Company Information
  15. 6.3.2 Baxter International Business Overview
  16. 6.3.3 Baxter International Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Baxter International Hemostatic Agents Product Portfolio
  18. 6.3.5 Baxter International Recent Developments
  19. 6.4 C. R. Bard
  20. 6.4.1 C. R. Bard Company Information
  21. 6.4.2 C. R. Bard Business Overview
  22. 6.4.3 C. R. Bard Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 C. R. Bard Hemostatic Agents Product Portfolio
  24. 6.4.5 C. R. Bard Recent Developments
  25. 6.5 The Medicines Company
  26. 6.5.1 The Medicines Company Company Information
  27. 6.5.2 The Medicines Company Business Overview
  28. 6.5.3 The Medicines Company Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 The Medicines Company Hemostatic Agents Product Portfolio
  30. 6.5.5 The Medicines Company Recent Developments
  31. 6.6 Anika Therapeutics
  32. 6.6.1 Anika Therapeutics Company Information
  33. 6.6.2 Anika Therapeutics Business Overview
  34. 6.6.3 Anika Therapeutics Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Anika Therapeutics Hemostatic Agents Product Portfolio
  36. 6.6.5 Anika Therapeutics Recent Developments
  37. 6.7 Advanced Medical Solutions
  38. 6.7.1 Advanced Medical Solutions Company Information
  39. 6.7.2 Advanced Medical Solutions Business Overview
  40. 6.7.3 Advanced Medical Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Advanced Medical Solutions Hemostatic Agents Product Portfolio
  42. 6.7.5 Advanced Medical Solutions Recent Developments
  43. 6.8 Integra LifeSciences
  44. 6.8.1 Integra LifeSciences Company Information
  45. 6.8.2 Integra LifeSciences Business Overview
  46. 6.8.3 Integra LifeSciences Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Integra LifeSciences Hemostatic Agents Product Portfolio
  48. 6.8.5 Integra LifeSciences Recent Developments
  49. 6.9 B Braun Melsungen
  50. 6.9.1 B Braun Melsungen Company Information
  51. 6.9.2 B Braun Melsungen Business Overview
  52. 6.9.3 B Braun Melsungen Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 B Braun Melsungen Hemostatic Agents Product Portfolio
  54. 6.9.5 B Braun Melsungen Recent Developments
  55. 6.10 Gelita Medical
  56. 6.10.1 Gelita Medical Company Information
  57. 6.10.2 Gelita Medical Business Overview
  58. 6.10.3 Gelita Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Gelita Medical Hemostatic Agents Product Portfolio
  60. 6.10.5 Gelita Medical Recent Developments
  61. 6.11 Equimedical
  62. 6.11.1 Equimedical Company Information
  63. 6.11.2 Equimedical Business Overview
  64. 6.11.3 Equimedical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Equimedical Hemostatic Agents Product Portfolio
  66. 6.11.5 Equimedical Recent Developments
  67. 6.12 Vascular Solutions
  68. 6.12.1 Vascular Solutions Company Information
  69. 6.12.2 Vascular Solutions Business Overview
  70. 6.12.3 Vascular Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Vascular Solutions Hemostatic Agents Product Portfolio
  72. 6.12.5 Vascular Solutions Recent Developments
  73. 6.13 Marine Polymer Technologies
  74. 6.13.1 Marine Polymer Technologies Company Information
  75. 6.13.2 Marine Polymer Technologies Business Overview
  76. 6.13.3 Marine Polymer Technologies Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Marine Polymer Technologies Hemostatic Agents Product Portfolio
  78. 6.13.5 Marine Polymer Technologies Recent Developments
  79. 6.14 Z-Medica
  80. 6.14.1 Z-Medica Company Information
  81. 6.14.2 Z-Medica Business Overview
  82. 6.14.3 Z-Medica Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Z-Medica Hemostatic Agents Product Portfolio
  84. 6.14.5 Z-Medica Recent Developments
  85. 6.15 CryoLife
  86. 6.15.1 CryoLife Company Information
  87. 6.15.2 CryoLife Business Overview
  88. 6.15.3 CryoLife Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 CryoLife Hemostatic Agents Product Portfolio
  90. 6.15.5 CryoLife Recent Developments
  91. 6.16 BioCer Entwicklungs
  92. 6.16.1 BioCer Entwicklungs Company Information
  93. 6.16.2 BioCer Entwicklungs Business Overview
  94. 6.16.3 BioCer Entwicklungs Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 BioCer Entwicklungs Hemostatic Agents Product Portfolio
  96. 6.16.5 BioCer Entwicklungs Recent Developments
  97. 6.17 Biom’Up SAS
  98. 6.17.1 Biom’Up SAS Company Information
  99. 6.17.2 Biom’Up SAS Business Overview
  100. 6.17.3 Biom’Up SAS Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Biom’Up SAS Hemostatic Agents Product Portfolio
  102. 6.17.5 Biom’Up SAS Recent Developments
7 North America by Country
  1. 7.1 North America Hemostatic Agents Sales by Country
  2. 7.1.1 North America Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hemostatic Agents Sales by Country (2021-2026)
  4. 7.1.3 North America Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hemostatic Agents Market Size by Country
  6. 7.2.1 North America Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hemostatic Agents Market Size by Country (2021-2026)
  8. 7.2.3 North America Hemostatic Agents Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hemostatic Agents Sales by Country
  2. 8.1.1 Europe Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hemostatic Agents Sales by Country (2021-2026)
  4. 8.1.3 Europe Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hemostatic Agents Market Size by Country
  6. 8.2.1 Europe Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hemostatic Agents Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hemostatic Agents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hemostatic Agents Sales by Country
  2. 9.1.1 Asia-Pacific Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hemostatic Agents Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hemostatic Agents Market Size by Country
  6. 9.2.1 Asia-Pacific Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hemostatic Agents Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hemostatic Agents Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hemostatic Agents Sales by Country
  2. 10.1.1 South America Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hemostatic Agents Sales by Country (2021-2026)
  4. 10.1.3 South America Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hemostatic Agents Market Size by Country
  6. 10.2.1 South America Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hemostatic Agents Market Size by Country (2021-2026)
  8. 10.2.3 South America Hemostatic Agents Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hemostatic Agents Sales by Country
  2. 11.1.1 Middle East and Africa Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hemostatic Agents Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hemostatic Agents Market Size by Country
  6. 11.2.1 Middle East and Africa Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hemostatic Agents Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hemostatic Agents Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hemostatic Agents Value Chain Analysis
  2. 12.1.1 Hemostatic Agents Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hemostatic Agents Production Mode & Process
  7. 12.2 Hemostatic Agents Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hemostatic Agents Distributors
  10. 12.2.3 Hemostatic Agents Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst